Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

FSR, in Partnership with ATS, Welcomes Dr. Matt Craig to Drive Strategic Research Initiatives

April 23, 2026

BEWARE SOFTWARE BRAIN | The Verge

April 23, 2026

Allsteel Unveils Newly Reimagined Boston Showroom Design

April 23, 2026

Take 5 Oil Change Grows Its Presence in Durham, North Carolina to Meet Demand for Convenient Car Care

April 23, 2026

Bitget Partners with Market Prophit to Expand Data-Driven Social Trading Capabilities

April 23, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Neoviva, Switzerland’s first addiction clinic offering guarantee
Press Release

Neoviva, Switzerland’s first addiction clinic offering guarantee

By News RoomJanuary 21, 20252 Mins Read
Neoviva, Switzerland’s first addiction clinic offering guarantee
Share
Facebook Twitter LinkedIn Pinterest Email

LUCERNE, Switzerland, Jan. 21, 2025 (GLOBE NEWSWIRE) — Neoviva, a leading luxury rehab centre launches Switzerland’s first and only assurance programme in addiction treatment. With a structured and tailored approach, Neoviva’s programme addresses the unique needs of each client, blending cutting-edge therapeutic methods with comprehensive aftercare. The Neoviva Guarantee is a testament to the effectiveness of their personalised Signature Programme and reflects confidence in the programme’s ability to help clients achieve sustainable recovery.

“Our track record speaks for itself, with countless success stories of lasting recovery. The Neoviva Guarantee is our way of putting action behind our words. We’re so convinced of our programme’s efficacy that we’re willing to stand by our clients long after they leave our facility. This isn’t just treatment; it’s a lifelong partnership in recovery,” states Fenina Erpf, CEO and Co-Founder of NEOVIVA, alongside Oliver Neubert, Founder of NEOVIVA.

Clients who complete a minimum of six weeks of Neoviva’s Signature programme and adhere to the 30-week continuing care plan are eligible for the Guarantee. Should a client relapse within one year of completing the programme, they may return for up to four weeks of additional intensive treatment at no extra cost.*

Nestled on the tranquil shores of Lake Lucerne, NEOVIVA’s luxury rehab facility blends world-class care with an exclusive and serene environment. Housed within a real-life hotel setting, our clinic offers the perfect balance of comfort, privacy, and discretion, ensuring a supportive space for recovery. This unique setting empowers clients with the tools and strategies needed to navigate life beyond treatment, all while immersed in the breathtaking beauty of the Swiss Alps.

About Neoviva:

Neoviva is a luxury rehab centre in Switzerland that offers personalised treatment plans for mental health and addiction treatment. With pioneering methodologies, a high staff-to-client ratio, and a commitment to profound personal transformation, Neoviva is more than a rehab centre—it is a life-changing experience for those seeking lasting recovery.

*Terms and conditions apply.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/22e5d7be-00e5-4d4c-9f88-fde0ffc48718


Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

FSR, in Partnership with ATS, Welcomes Dr. Matt Craig to Drive Strategic Research Initiatives

Allsteel Unveils Newly Reimagined Boston Showroom Design

Take 5 Oil Change Grows Its Presence in Durham, North Carolina to Meet Demand for Convenient Car Care

Bitget Partners with Market Prophit to Expand Data-Driven Social Trading Capabilities

AriseAlpha Expands Free AI Stock Trading Bot to Support Faster Passive Income in 2026

The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic

Biologics Active Pharmaceutical Ingredient (API) Market Worth $101.8 Billion by 2030, Witnessing 8.8% CAGR

Polyphenylene Sulfide (PPS) Market Projected to Hit $2.9 Billion by 2032 – PPS Compounds Dominate, Driving Automotive and Aerospace Demand

Wärtsilä continues to expand its data center footprint with new 790 MW order in Texas, the next Data Center Alley

Editors Picks

BEWARE SOFTWARE BRAIN | The Verge

April 23, 2026

Allsteel Unveils Newly Reimagined Boston Showroom Design

April 23, 2026

Take 5 Oil Change Grows Its Presence in Durham, North Carolina to Meet Demand for Convenient Car Care

April 23, 2026

Bitget Partners with Market Prophit to Expand Data-Driven Social Trading Capabilities

April 23, 2026

Latest News

AriseAlpha Expands Free AI Stock Trading Bot to Support Faster Passive Income in 2026

April 23, 2026

The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic

April 23, 2026

Biologics Active Pharmaceutical Ingredient (API) Market Worth $101.8 Billion by 2030, Witnessing 8.8% CAGR

April 23, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version